JPWO2023094818A5 - - Google Patents

Info

Publication number
JPWO2023094818A5
JPWO2023094818A5 JP2024530529A JP2024530529A JPWO2023094818A5 JP WO2023094818 A5 JPWO2023094818 A5 JP WO2023094818A5 JP 2024530529 A JP2024530529 A JP 2024530529A JP 2024530529 A JP2024530529 A JP 2024530529A JP WO2023094818 A5 JPWO2023094818 A5 JP WO2023094818A5
Authority
JP
Japan
Prior art keywords
composition
biopharmaceutical
disaccharide
pharmaceutically acceptable
biopharmaceutical compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024530529A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024543125A (ja
JP2024543125A5 (https=
Publication date
Priority claimed from GBGB2117005.5A external-priority patent/GB202117005D0/en
Priority claimed from GBGB2208144.2A external-priority patent/GB202208144D0/en
Priority claimed from GBGB2213306.0A external-priority patent/GB202213306D0/en
Application filed filed Critical
Priority claimed from PCT/GB2022/052985 external-priority patent/WO2023094818A1/en
Publication of JP2024543125A publication Critical patent/JP2024543125A/ja
Publication of JPWO2023094818A5 publication Critical patent/JPWO2023094818A5/ja
Publication of JP2024543125A5 publication Critical patent/JP2024543125A5/ja
Pending legal-status Critical Current

Links

JP2024530529A 2021-11-25 2022-11-25 バイオ医薬品化合物を含む医薬組成物 Pending JP2024543125A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB2117005.5A GB202117005D0 (en) 2021-11-25 2021-11-25 New pharmaceutical composition
GB2117005.5 2021-11-25
GB2208144.2 2022-06-01
GBGB2208144.2A GB202208144D0 (en) 2022-06-01 2022-06-01 New pharmaceutical composition
GB2213306.0 2022-09-12
GBGB2213306.0A GB202213306D0 (en) 2022-09-12 2022-09-12 New pharmaceutical composition
PCT/GB2022/052985 WO2023094818A1 (en) 2021-11-25 2022-11-25 Pharmaceutical composition comprising biopharmaceutical drug compounds

Publications (3)

Publication Number Publication Date
JP2024543125A JP2024543125A (ja) 2024-11-19
JPWO2023094818A5 true JPWO2023094818A5 (https=) 2025-12-02
JP2024543125A5 JP2024543125A5 (https=) 2025-12-02

Family

ID=84367624

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024530529A Pending JP2024543125A (ja) 2021-11-25 2022-11-25 バイオ医薬品化合物を含む医薬組成物

Country Status (11)

Country Link
US (1) US20240408212A1 (https=)
EP (1) EP4436551A1 (https=)
JP (1) JP2024543125A (https=)
KR (1) KR20240111761A (https=)
AR (1) AR127783A1 (https=)
AU (1) AU2022398370A1 (https=)
CA (1) CA3239053A1 (https=)
IL (1) IL313015A (https=)
MX (1) MX2024006130A (https=)
TW (1) TW202329916A (https=)
WO (1) WO2023094818A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12414916B2 (en) 2021-06-10 2025-09-16 Belhaven BioPharma Inc. Dry powder formulations of epinephrine and associated methods
US20260108686A1 (en) 2024-10-21 2026-04-23 Belhaven BioPharma Inc. Compositions, devices, and methods for intranasal delivery of dry powder epinephrine

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19518810A1 (de) 1995-05-26 1996-11-28 Bayer Ag Nasal-Applikator
DE69913113T2 (de) 1998-03-10 2004-08-26 Valois S.A.S. Behälter, verfahren zur befüllung dieses behälter und abgabevorrichtung für das im behälter enthaltene pulver
FR2817847B1 (fr) 2000-12-08 2003-03-28 Tebro Dispositif de distribution de produit fluide ou pulverulent
LU90825B1 (en) 2001-09-06 2003-03-07 Iee Sarl Method for the determination of one or more parameters of a seat passenger
AU2003272959A1 (en) 2003-10-09 2005-04-27 Bioactis Limited Powdery medicine dispensing device for nasal cavity
EP1834651A1 (en) * 2006-03-15 2007-09-19 Universiteit Gent Compositions and methods for veterinary vaccination
WO2009090189A1 (en) * 2008-01-15 2009-07-23 Abbott Gmbh & Co.Kg Powdered protein compositions and methods of making same
EP2266563A1 (en) 2009-06-11 2010-12-29 Charité-Universitätsmedizin Berlin (Charité) Use of opioid receptor antagonists for acute treatment of paraphilic arousal states
GB2472327B (en) 2009-07-31 2013-03-13 Shin Nippon Biomedical Lab Ltd Intranasal granisetron and nasal applicator
JP5623355B2 (ja) 2010-07-30 2014-11-12 オートリブ ディベロップメント エービー カーテンエアバッグ
WO2014004400A2 (en) 2012-06-28 2014-01-03 The Governt. Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Nasal dry powder delivery system for vaccines and other treatment agents
FR3007992B1 (fr) 2013-07-05 2018-01-26 Aptar France Sas Dispositif de distribution de produit fluide ou pulverulent.
RU2720808C2 (ru) * 2013-09-03 2020-05-13 Джорджия Тек Рисёч Корпорейшн Термостабильные препараты вакцин и микроиглы
CN104489669A (zh) * 2014-12-12 2015-04-08 深圳先进技术研究院 一种植物酵素益生菌粉及其制备方法
US11331270B2 (en) 2017-08-20 2022-05-17 Nasus Pharma Ltd. Dry powder compositions for intranasal delivery
EP3698773A1 (en) * 2019-02-21 2020-08-26 Università degli Studi di Parma Composition and manufacturing of powders containing nanoadjuvants for mucosal vaccination
US10653690B1 (en) * 2019-07-09 2020-05-19 Orexo Ab Pharmaceutical composition for nasal delivery
FR3098420B1 (fr) 2019-07-10 2021-07-09 Aptar France Sas Dispositif de distribution nasale de poudre
RS63725B1 (sr) * 2020-05-18 2022-12-30 Orexo Ab Nova farmaceutska kompozicija za davanje leka
FR3121047B1 (fr) 2021-03-29 2023-07-14 Aptar France Sas Dispositif de distribution nasale de poudre

Similar Documents

Publication Publication Date Title
EP1598066B1 (en) Powder inhalant of sumatriptan and the method of preparation thereof
CN102149368B (zh) 治疗剂通过粘膜或皮肤吸收的改善
KR100208979B1 (ko) 기도내 투여용 제제
US6586006B2 (en) Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
MD3962455T2 (ro) Compoziție farmaceutică nouă pentru livrare de medicamente
US20040219206A1 (en) Solid dose delivery vehicle and methods of making same
EP1516615A2 (en) Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
KR20070111497A (ko) 약의 경점막 투여에 유용한 새로운 약학 조성물
TW201113259A (en) Diketopiperazine microparticles with defined isomer contents
KR20020060218A (ko) 개선된 분산성을 갖는 건조 분말 조성물
JP2002523360A (ja) 安定な噴霧乾燥タンパク質製剤
JPWO2021234366A5 (https=)
CN103717231A (zh) 干粉万古霉素组合物以及相关方法
KR20240103005A (ko) 아드레날린을 포함하는 약학적 조성물
RU2327446C2 (ru) Состав с высвобождением в толстом кишечнике
RU2013140974A (ru) Способ получения продуктов, содержащих стабилизированные активные вещества, и композиций, содержащих таковые
KR20240111769A (ko) 비강내 투여에 사용되는 새로운 약학적 장치
ES2339423T3 (es) Composiciones terapeuticas para administracion pulmonar.
JPWO2021005325A5 (https=)
US6310089B1 (en) Composition for the administration of a D1-agonists
WO2002015876A2 (en) Amorphous carrier materials for drug delivery
ES2357607T3 (es) Composiciones intranasales.
JPWO2023094818A5 (https=)
CN102580056B (zh) 一种含抗利尿成分的缓释注射剂及其制备方法
GB2395900A (en) Therapeutic composition for respiratory delivery